Keywords: vertex, initiates, ph, ii, trial, vx-950, hep

Vertex initiates Ph II trial of VX-950 in hep C

Article | 12 December 2005

Print This

USA-based Vertex Pharmaceuticals has announced the initiation of a Phase II clinical trial for VX-950, an investigational oral hepatitis C ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in